BUSINESS: Global Coronavirus Disease, (COVID-19), Clinical Trials Review. H2 2021 – Region (G7 &E7), Phase. Trial Status, End Points Status And Sponsor Type

dWeb.News Article from Daniel Webster dWeb.News

dWeb.News Article from Daniel Webster dWeb.News

by Daniel Webster, dWeb.News Publisher

Searching for your content…

DUBLIN, Oct. 11, 2021 /PRNewswire/ — The “Coronavirus Disease 2019 (COVID-19) – Global Clinical Trials Review, H2, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering.

The clinical trial report provides an overview of Coronavirus Disease 2019 (COVID-19) Clinical trials scenario.

This report provides top line data relating to the clinical trials on Coronavirus Disease 2019 (COVID-19) . This report includes an overview of trial numbers in top countries and their average enrollment. The report provides information on disease clinical trials by country (G7 and E7), phase status, end points status, sponsor type, and region.

Report also lists prominent drugs in-progress trials (based upon the number of ongoing trials). 35350

Scope

the report provides a snapshot of the global clinical trials landscape
Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
the report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
the report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
the Report provides enrollment trends for the past five years
Report provides latest news for the past three months

Reasons to Buy

Assists in formulating key business strategies with regards to investment
Helps in identifying prominent locations for conducting clinical trials which saves time and cost
Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
Supports understanding of trials count and enrollment trends by country in global therapeutics market
Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
Facilitates clinical trial assessment of the indication on a global, regional and country level

Clinical Trials Report Coverage

Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Coronavirus Disease 2019 (COVID-19) to Infectious Disease Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Coronavirus Disease 2019 (COVID-19) to Infectious Disease Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials
Prominent Drugs
Clinical Trial Profile Snapshots

Companies Mentioned

AstraZeneca Plc
Pfizer Inc
F. Hoffmann-La Roche Ltd
IQVIA Holdings Inc
PPD Inc
Novartis AG
GlaxoSmithKline Plc
Johnson & Johnson
Sorrento Therapeutics Inc
Eli Lilly and Co

For more information about this clinical trials report visit https://www.researchandmarkets.com/r/lkimch

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com

Also from this source

Read More

Section B Business News – dWeb.News

More dWeb.News Business News at https://dweb.news/category/dweb-news/section-b-business-news/

Similar Posts